{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:13:09Z","timestamp":1780567989745,"version":"3.54.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,16]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>STUDY QUESTION<\/jats:title><jats:p>Is oocyte cryopreservation an applicable option for fertility preservation in unmarried patients with haematological malignancies?<\/jats:p><\/jats:sec><jats:sec><jats:title>SUMMARY ANSWER<\/jats:title><jats:p>Oocyte cryopreservation via the vitrification method is accessible and may be considered an option for fertility preservation in unmarried patients with haematological malignancies.<\/jats:p><\/jats:sec><jats:sec><jats:title>WHAT IS KNOWN ALREADY<\/jats:title><jats:p>Haematological malignancies are most commonly observed amongst adolescent and young adult women. Although the survival rate and life expectancy of those with haematological malignancies have improved, chemotherapy and radiotherapy may impair their reproductive potential. Oocyte cryopreservation is thus an ideal option to preserve their fertility.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title><jats:p>This study retrospectively evaluated 193 unmarried patients (age: 26.2\u2009\u00b1\u20090.4\u2009years) with haematological malignancies, who consulted for oocyte cryopreservation across 20 different fertility centres in Japan between February 2007 and January 2015. The primary outcome measures were the oocyte retrievals and oocyte cryopreservation outcomes. The secondary outcome measures were the outcomes following oocyte warming for IVF.<\/jats:p><\/jats:sec><jats:sec><jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title><jats:p>The patients had commenced ovarian stimulation cycles via antagonist, agonist, natural and minimal methods for oocyte retrievals, defined according to the treatment strategy of each respective fertility centre. A vitrification method using the Cryotop safety kit was used for oocyte cryopreservation. ICSIs were used for insemination of warmed oocytes. The endometrial preparation method for embryo transfer was hormonal replacement therapy, except in the case of a patient who underwent a spontaneous ovulatory cycle.<\/jats:p><\/jats:sec><jats:sec><jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title><jats:p>Among 193 patients, acute myeloid leukaemia (n\u2009=\u200945, 23.3%) was most common, followed by acute lymphoid leukaemia (n\u2009=\u200938, 19.7%) and Hodgkin\u2019s lymphoma (n\u2009=\u200930, 15.5%). In total, 162 patients (83.9%) underwent oocyte retrieval, and oocytes were successfully cryopreserved for 155 patients (80.3%). The mean number of oocyte retrieval cycles and cryopreserved oocytes were 1.7\u2009\u00b1\u20090.2 and 6.3\u2009\u00b1\u20090.4, respectively. As of December 2019, 14 patients (9.2%) had requested oocyte warming for IVF. The survival rate of oocytes after vitrification-warming was 85.2% (75\/88). The rates of fertilisation and embryo development were 80.0% (60\/75) and 46.7% (28\/60), respectively. Ten patients (71.4%) had successful embryo transfers, and seven live births (50.0%) were achieved.<\/jats:p><\/jats:sec><jats:sec><jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title><jats:p>This study was limited by its retrospective nature. Additionally, there remains an insufficient number of cases regarding the warming of vitrified oocytes to reliably conclude whether oocyte cryopreservation is effective for patients with haematological malignancies. Further long-term follow-up study is required.<\/jats:p><\/jats:sec><jats:sec><jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title><jats:p>Oocyte retrieval and oocyte cryopreservation were accessible for patients with haematological malignancies; however, the number of oocyte retrievals may have been limited due to the initiation of cancer treatments. Acceptable embryonic and pregnancy outcomes could be achieved following oocyte warming; therefore, our results suggest that oocyte cryopreservation can be considered an option for fertility preservation in patients with haematological malignancies.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY FUNDING\/COMPETING INTERESTS<\/jats:title><jats:p>This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. The authors declare no conflict of interest.<\/jats:p><\/jats:sec><jats:sec><jats:title>TRIAL REGISTRATION NUMBER<\/jats:title><jats:p>N\/A<\/jats:p><\/jats:sec>","DOI":"10.1093\/hropen\/hoaa064","type":"journal-article","created":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T12:39:46Z","timestamp":1607776786000},"source":"Crossref","is-referenced-by-count":14,"title":["A multi-centre, retrospective case series of oocyte cryopreservation in unmarried women diagnosed with haematological malignancies"],"prefix":"10.1093","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-4532","authenticated-orcid":false,"given":"K","family":"Kato","sequence":"first","affiliation":[{"name":"Kato Ladies Clinic, Tokyo 160-0023, Japan"},{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ochi","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Ochi Yume Clinic Nagoya, Nagoya, Aichi 460-0002, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Nakamura Ladies Clinic, Suita, Osaka 564-0051, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Kamiya Ladies Clinic, Sapporo, Hokkaido 060-0003, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Utsunomiya","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"St. Luke Clinic, Oita, 870-0823 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yano","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Yano Maternity Clinic, Matsuyama, Ehime 790-0872, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Michikura","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Kanazawa Tamago Clinic, Kanazawa, Ishikawa 920-0016, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hara","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Hiroshima Prefectural Hospital, Hiroshima 734-8530, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kyono","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Kyono ART Clinic Sendai, Sendai, Miyagi 980-0014, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Takeuchi Ladies Clinic, Aira, Kagoshima 899-5421, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Adachi Hospital, Chuo-ku, Kyoto 604-0837, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Iwamasa","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Sofia Ladies Clinic Suidocho, Chuo-ku, Kumamoto 860-0844, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Mio","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Mio Fertility Clinic, Yonago, Totttori 683-0008, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kuramoto","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Kuramoto Women\u2019s Clinic, Hakata-ku, Fukuoka 812-0013, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Nagata","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"IVF Nagata Clinic, Chuo-ku, Fukuoka 810-0001, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Jo","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Jo Clinic, Nishinomiya, Hyogo 860-0844, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Asada","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Asada Ladies Clinic, Nagoya, Aichi 450-0002, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ohishi","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Hamanomachi Hospital, Fukuoka 810-0072, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Osada","sequence":"additional","affiliation":[{"name":"Kato Ladies Clinic, Tokyo 160-0023, Japan"},{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Natural ART Clinic Nihombashi, Chuo-ku, Tokyo 103-6008, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Japan Association of Private Assisted Reproductive Technology Clinics and Laboratories (Japan A-PART), Tokyo 160-0023, Japan"},{"name":"Kato Ladies Clinic, Tokyo 160-0023, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,16]]},"reference":[{"key":"2021011600143193200_hoaa064-B1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.reprotox.2010.07.003","article-title":"Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes","volume":"30","author":"Bar-Joseph","year":"2010","journal-title":"Reprod Toxicol"},{"key":"2021011600143193200_hoaa064-B2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1472-6483(10)60239-8","article-title":"Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients","volume":"17","author":"Demirtas","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"2021011600143193200_hoaa064-B3","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.fertnstert.2013.03.027","article-title":"Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue","volume":"99","author":"Dolmans","year":"2013","journal-title":"Fertil Steril"},{"key":"2021011600143193200_hoaa064-B4","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2010-01-265751","article-title":"Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe","volume":"116","author":"Dolmans","year":"2010","journal-title":"Blood"},{"key":"2021011600143193200_hoaa064-B5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(04)17222-X","article-title":"Livebirth after orthotopic transplantation of cryopreserved ovarian tissue","volume":"364","author":"Donnez","year":"2004","journal-title":"Lancet"},{"key":"2021011600143193200_hoaa064-B6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.repbio.2014.04.007","article-title":"Long-term adverse effects of cyclophosphamide on follicular growth and angiogenesis in mouse ovaries","volume":"14","author":"Ezoe","year":"2014","journal-title":"Reprod Biol"},{"key":"2021011600143193200_hoaa064-B7","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.fertnstert.2013.02.004","article-title":"Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications","volume":"99","author":"Garcia-Velasco","year":"2013","journal-title":"Fertil Steril"},{"key":"2021011600143193200_hoaa064-B8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.fertnstert.2009.02.067","article-title":"Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients","volume":"93","author":"Grifo","year":"2010","journal-title":"Fertil Steril"},{"key":"2021011600143193200_hoaa064-B9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GCO.0b013e32834874e2","article-title":"Current status of human oocyte and embryo cryopreservation","volume":"23","author":"Herrero","year":"2011","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2021011600143193200_hoaa064-B10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/jjco\/hyx070","article-title":"Childhood, adolescent and young adult cancer incidence in Japan in 2009-2011","volume":"47","author":"Katanoda","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"2021011600143193200_hoaa064-B11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7827-10-35","article-title":"Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort","volume":"10","author":"Kato","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"2021011600143193200_hoaa064-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/307268","article-title":"Cryopreservation of embryos and oocytes in human assisted reproduction","volume":"2014","author":"Konc","year":"2014","journal-title":"Biomed Res Int"},{"key":"2021011600143193200_hoaa064-B13","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021011600143193200_hoaa064-B14","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility preservation for patients with cancer: American Society","volume":"31","author":"Loren","year":"2013","journal-title":"J Clin Oncol"},{"key":"2021011600143193200_hoaa064-B15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.fertnstert.2010.06.064","article-title":"Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation","volume":"95","author":"Maman","year":"2011","journal-title":"Fertil Steril"},{"key":"2021011600143193200_hoaa064-B16","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.rbmo.2014.09.002","article-title":"Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer","volume":"29","author":"Martinez","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2021011600143193200_hoaa064-B17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"2021011600143193200_hoaa064-B18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/humrep\/dev013","article-title":"A preliminary study on a new model system to evaluate tumour-detection and tumour-purging protocols in ovarian cortex tissue intended for fertility preservation","volume":"30","author":"Peek","year":"2015","journal-title":"Hum Reprod"},{"key":"2021011600143193200_hoaa064-B19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00404-017-4594-3","article-title":"Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: indications for fertility preservation","volume":"297","author":"Sch\u00fcring","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2021011600143193200_hoaa064-B20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10815-015-0519-x","article-title":"IVF for fertility preservation in breast cancer patients\u2013efficacy and safety issues","volume":"32","author":"Shapira","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2021011600143193200_hoaa064-B21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/humrep\/deu353","article-title":"Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency","volume":"30","author":"Suzuki","year":"2015","journal-title":"Hum Reprod"},{"key":"2021011600143193200_hoaa064-B22","first-page":"S241","volume":"90","author":"The Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology. Ovarian tissue and oocyte cryopreservation","year":"2008","journal-title":"Fertil Steril"},{"key":"2021011600143193200_hoaa064-B23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00404-017-4595-2","article-title":"Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part II: fertility preservation techniques","volume":"297","author":"von Wolff","year":"2018","journal-title":"Arch Gynecol Obstet"}],"container-title":["Human Reproduction Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hropen\/article-pdf\/2021\/1\/hoaa064\/35888773\/hoaa064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/hropen\/article-pdf\/2021\/1\/hoaa064\/35888773\/hoaa064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T10:39:35Z","timestamp":1618655975000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hropen\/article\/doi\/10.1093\/hropen\/hoaa064\/6102106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/hropen\/hoaa064","relation":{},"ISSN":["2399-3529"],"issn-type":[{"value":"2399-3529","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021]]},"published":{"date-parts":[[2021]]},"article-number":"hoaa064"}}